Task force on women's medical procedural pain established, and report required.
Summary
HF4515 establishes a temporary Minnesota task force on women’s medical procedural pain. The bill defines the topic broadly but specifically identifies cesarean section, cervical biopsy, endometrial biopsy, intrauterine device insertion and removal, and hysteroscopy as procedures of concern. The task force is charged with collecting and analyzing data on these procedures, hearing from affected women and health care professionals, and examining ways to reduce the number of procedures or identify alternatives.
The task force would be appointed by the commissioner of health and include physicians in obstetrics/gynecology and primary care, pain-management professionals, women who have personally experienced procedural pain, and ex officio representatives from the Department of Health and the Board of Medical Practice. It must meet at least quarterly, operate under the Open Meeting Law, and submit a report with findings and legislative recommendations by January 1, 2028, after which it expires. The bill takes effect the day after final enactment.
Impact
The bill does not directly change clinical practice standards or create new patient rights in statute; instead, it creates a temporary advisory body within the health system to study women’s procedural pain and recommend possible legislative action. Its immediate legal effect is to require the Department of Health to convene and support the task force, reimburse members’ expenses under existing law, and ensure compliance with open meeting requirements. Any substantive changes to health care procedures, pain management, or informed-consent rules would depend on future legislation prompted by the task force’s report.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be framed as a study-and-recommendation bill rather than a controversial regulatory change. Its structure suggests a generally exploratory and policy-oriented approach, with emphasis on gathering evidence and patient experience. There is no available voting history or transcript indicating opposition, support, or amendment debate.
Contention
The main potential points of contention are likely to center on whether a task force is the best mechanism for addressing women’s procedural pain, what procedures should be prioritized, and whether the bill should lead to concrete practice changes or remain advisory. Stakeholders may differ on the scope of the study, especially around procedures such as IUD insertion/removal, biopsies, and hysteroscopy, and on how much weight should be given to patient-reported pain versus clinical necessity. Another possible issue is whether the task force’s recommendations could imply broader mandates for providers or insurers in future legislation.